Literature DB >> 23744071

α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.

Iryna Prots1, Vanesa Veber, Stefanie Brey, Silvia Campioni, Katrin Buder, Roland Riek, Konrad J Böhm, Beate Winner.   

Abstract

Early α-synuclein (α-Syn)-induced alterations are neurite pathologies resulting in Lewy neurites. α-Syn oligomers are a toxic species in synucleinopathies and are suspected to cause neuritic pathology. To investigate how α-Syn oligomers may be linked to aberrant neurite pathology, we modeled different stages of α-Syn aggregation in vitro and investigated the interplay of α-Syn aggregates with proteins involved in axonal transport. The interaction of wild type α-Syn (WTS) and α-Syn variants (E57K, A30P, and aSyn(30-110)) with kinesin, tubulin, and the microtubule (MT)-associated proteins, MAP2 and Tau, is stronger for multimers than for monomers. WTS seeds but not α-Syn oligomers significantly and dose-dependently reduced Tau-promoted MT assembly in vitro. In contrast, MT gliding velocity across kinesin-coated surfaces was significantly decreased in the presence of α-Syn oligomers but not WTS seeds or fibrils (aSyn(30-110) multimers). In a human dopaminergic neuronal cell line, mild overexpression of the oligomerizing E57K α-Syn variant significantly impaired neurite network morphology without causing profound cell death. In accordance with these findings, MT stability, neuritic kinesin, and neuritic kinesin-dependent cargoes were significantly reduced by the presence of α-Syn oligomers. In summary, different α-Syn species act divergently on the axonal transport machinery. These findings provide new insights into α-Syn oligomer-driven neuritic pathology as one of the earliest events in synucleinopathies.

Entities:  

Keywords:  Kinesin; Microtubules; Neurite; Neurodegeneration; Oligomers; Transport; alpha-Synuclein

Mesh:

Substances:

Year:  2013        PMID: 23744071      PMCID: PMC3724632          DOI: 10.1074/jbc.M113.451815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Impairment of microtubule system increases alpha-synuclein aggregation and toxicity.

Authors:  Myunghye Kim; Wonsuk Jung; In-Hwan Lee; Ghibom Bhak; Seung R Paik; Ji-Sook Hahn
Journal:  Biochem Biophys Res Commun       Date:  2007-11-20       Impact factor: 3.575

2.  Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line.

Authors:  Diana Scholz; Dominik Pöltl; Andreas Genewsky; Matthias Weng; Tanja Waldmann; Stefan Schildknecht; Marcel Leist
Journal:  J Neurochem       Date:  2011-04-13       Impact factor: 5.372

3.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

4.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

5.  Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy.

Authors:  Kimiko Nakayama; Yasuyo Suzuki; Ikuru Yazawa
Journal:  Biochem Biophys Res Commun       Date:  2011-12-29       Impact factor: 3.575

6.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

7.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

8.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

9.  Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.

Authors:  Tetyana Duka; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  FASEB J       Date:  2009-04-15       Impact factor: 5.191

10.  Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.

Authors:  Damla Pinar Karpinar; Madhu Babu Gajula Balija; Sebastian Kügler; Felipe Opazo; Nasrollah Rezaei-Ghaleh; Nora Wender; Hai-Young Kim; Grit Taschenberger; Björn H Falkenburger; Henrike Heise; Ashutosh Kumar; Dietmar Riedel; Lars Fichtner; Aaron Voigt; Gerhard H Braus; Karin Giller; Stefan Becker; Alf Herzig; Marc Baldus; Herbert Jäckle; Stefan Eimer; Jörg B Schulz; Christian Griesinger; Markus Zweckstetter
Journal:  EMBO J       Date:  2009-09-10       Impact factor: 11.598

View more
  69 in total

1.  β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.

Authors:  Yasuyo Suzuki; Chenghua Jin; Tamaki Iwase; Ikuru Yazawa
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

Review 2.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

Review 3.  The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.

Authors:  Danielle E Mor; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Mov Disord       Date:  2019-01-11       Impact factor: 10.338

Review 4.  The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Authors:  J Schapansky; J D Nardozzi; M J LaVoie
Journal:  Neuroscience       Date:  2014-10-02       Impact factor: 3.590

5.  Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.

Authors:  Huajun Jin; Arthi Kanthasamy; Dilshan S Harischandra; Naveen Kondru; Anamitra Ghosh; Nikhil Panicker; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

6.  HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.

Authors:  Ying Wang; Maryline Santerre; Italo Tempera; Kayla Martin; Ruma Mukerjee; Bassel E Sawaya
Journal:  Neuropharmacology       Date:  2017-02-14       Impact factor: 5.250

7.  Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.

Authors:  Hossein Mohammad-Beigi; Farhang Aliakbari; Cagla Sahin; Charlotte Lomax; Ahmed Tawfike; Nicholas P Schafer; Alireza Amiri-Nowdijeh; Hoda Eskandari; Ian Max Møller; Mehdi Hosseini-Mazinani; Gunna Christiansen; Jane L Ward; Dina Morshedi; Daniel E Otzen
Journal:  J Biol Chem       Date:  2019-01-17       Impact factor: 5.157

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

Review 9.  Microtubule Destabilization Paves the Way to Parkinson's Disease.

Authors:  D Cartelli; G Cappelletti
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

10.  Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction.

Authors:  Ming Gan; Simon Moussaud; Peizhou Jiang; Pamela J McLean
Journal:  Neurobiol Aging       Date:  2014-11-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.